01/13/2025
3:18 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:23 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
6:15 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
6:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
6:31 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:00 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:10 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
6:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:05 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
4:00 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:28 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/15/2024
7:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
7:05 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form NT 10-Q | |
08/14/2024
8:46 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Ramdeen Timothy R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:20 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
9:54 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:16 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/23/2024
3:05 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
7:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
1:33 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:34 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
7:03 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/20/2024
3:30 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:23 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form PRER14A | |
06/14/2024
4:15 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 424B3 | |
06/12/2024
5:23 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
11:15 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
4:15 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:25 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/30/2024
4:18 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K/A | |
05/30/2024
4:32 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form DEFA14A | |
05/16/2024
6:16 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
4:26 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
4:26 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:59 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 424B5 | |
05/08/2024
4:16 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K/A | |
03/29/2024
3:16 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
4:00 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:40 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:31 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form DEFA14A | |
03/15/2024
5:00 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Did You See Trump’s Manhattan Project Bombshell? (Ad) This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House.
Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)...
Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years.  Click here and see for yourself. |
03/15/2024
5:00 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
5:05 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
5:05 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
5:10 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form DEFA14A | |
03/14/2024
5:09 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:29 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 424B5 | |
02/14/2024
1:45 PM | ARMISTICE CAPITAL, LLC (Filed by)
First Wave BioPharma, Inc. (Subject)
First Wave BioPharma, Inc. (Subject)
Entero Therapeutics (Subject)
| Form SC 13G/A | |
Free ENTO Stock Alerts